Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
04/2002
04/18/2002WO2002030931A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
04/18/2002WO2002030930A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
04/18/2002WO2002030929A1 Novel pleuromutilin derivatives
04/18/2002WO2002030881A1 Sulfonylguanidine
04/18/2002WO2002030405A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
04/18/2002US20020045753 E.g., (S)-N-(4-(4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2 -yl)-carbonyl)-1-piperazinyl)phenyl)-2-thiophenecarboximidamide , or a salt thereof.
04/18/2002CA2424107A1 Sulfonylguanidines
04/17/2002EP1196500A1 Reactive dye compounds
04/17/2002EP1196430A2 Purification and stabilization of peptide and proteins in pharmaceutical agents
04/17/2002EP1196404A1 Piperazine derivatives as modulators of chemokine receptor activity
04/17/2002EP1196397A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
04/17/2002EP1196396A1 Conjugates of sodium channel blockers and methods of using the same
04/17/2002EP1196395A1 Cyclized amino acid derivatives
04/17/2002EP1196388A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
04/17/2002EP1196384A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
04/17/2002CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors
04/17/2002CN1344717A Quaternary ammonium salt compound of piperazine with pain relieving effect
04/17/2002CN1082964C Novel chiral bisphosphines
04/16/2002US6372885 Solid-phase technology for the preparation of amides
04/16/2002US6372750 Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
04/16/2002US6372682 Contacting one or more olefin monomers with a group 8-10 transition metal complex catalyst and optionally a bronsted or lewis acid
04/16/2002CA2009690C Phenylhydrazones, the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom
04/11/2002WO2002029021A2 Biotechnological method for preparing carboxylic acids with a hydroxy-nitrogen heterocycle
04/11/2002WO2002028871A1 Platinum complexes as antitumor agents
04/11/2002WO2002028842A2 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonist
04/11/2002WO2002028835A1 Benzamide compounds as apo b secretion inhibitors
04/11/2002WO2002028823A1 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation and their use
04/11/2002US20020042511 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
04/11/2002US20020042414 Antiallergens
04/11/2002US20020042399 Analgesics; skin disorders
04/11/2002CA2425097A1 Benzamide compounds as apo b secretion inhibitors
04/11/2002CA2424282A1 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonist
04/10/2002EP1194152A1 Src kinase inhibitor compounds
04/10/2002EP0734387B1 Hiv protease inhibitors
04/10/2002CN1344266A Novel compounds
04/10/2002CN1082508C antivirally active heterocyclic azahexane derivatives
04/09/2002USRE37650 Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
04/09/2002US6369220 Oxidizing an aryl-3-hydroxypropylsulfide; oxidizing 3-hydroxy group into aryl-3-propanalsulfoxide; cyclization
04/09/2002US6369057 Quinoxalines, processes for their preparation and their use
04/04/2002WO2002026734A1 PIPERAZIN-2-ONE AMIDES AS INHIBITORS OF FACTOR Xa
04/04/2002WO2001090079A3 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
04/04/2002WO2001047898A3 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp)
04/04/2002US20020040156 Useful as photographic bleaching agent, a fertilizer, biodegradability
04/04/2002US20020040025 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
04/04/2002US20020040002 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
04/04/2002US20020039997 Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
04/04/2002CA2422873A1 Piperazin-2-one amides as inhibitors of factor xa
04/03/2002EP1193254A1 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method of using the same
04/03/2002EP1193250A1 Phenyl sulfamate derivatives
04/03/2002EP1193248A1 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation and their use
04/03/2002EP1192136A2 Oligomers and polymers of cyclic imino carboxylic acids
04/03/2002EP1192135A2 Serine protease inhibitors
04/03/2002EP1192132A2 Serine protease inhibitors
04/03/2002EP1192129A2 Pharmaceutical compounds
04/02/2002US6365741 Reacting (i) a diisopropanolamine mixture or (ii) 1,2-diaminopropane with ammonia and hydrogen in the presence of a hydrogenation catalyst.
04/02/2002US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
04/02/2002US6365068 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
04/02/2002CA2059610C 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[b]indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments
03/2002
03/28/2002WO2002024681A2 Pyrazine derivatives as modulators of tyrosine kinases
03/28/2002WO2002024636A2 N-acylsulfonamide apoptosis promoters
03/28/2002WO2002024635A2 Aminoalcohol derivatives
03/28/2002US20020038026 Method of synthesizing diketopiperazines
03/28/2002CA2423050A1 Pyrazine derivatives as modulators of tyrosine kinases
03/27/2002EP1189887A2 Process for preparing 10,11-methanobenzosuberane derivatives
03/27/2002EP1189875A2 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers
03/27/2002EP0822931B1 Piperazinones useful as inhibitors of platelet aggregation
03/27/2002EP0651746B1 Drugs that enhance synaptic responses mediated by ampa receptors
03/27/2002CN1342151A 喹啉和喹喔啉化合物 Quinoline and quinoxaline compounds
03/27/2002CN1342150A Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors
03/27/2002CN1342137A N2 phenylamidine derivatives
03/27/2002CN1341593A Proteinase inhibitor
03/27/2002CN1341592A Proteinase inhibitor
03/27/2002CN1341590A Proteinase inhibitor
03/27/2002CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists
03/26/2002US6362371 β2- adrenergic receptor agonists
03/26/2002US6362231 Calcium receptor active compounds
03/26/2002US6362200 Antitumor dibenzofluorene derivatives
03/26/2002US6362185 Polyhydroxyalkylpyrazine derivatives, their preparation and the medicaments comprising them
03/21/2002WO2001095858A3 Piperazinedione compounds
03/21/2002WO2001079193A3 Substituted hydrazinyl heteroaromatic inhibitors of thrombin
03/21/2002US20020035285 Hydrogenation catalyst
03/21/2002US20020035256 Novel synthesis of piperazine ring
03/21/2002US20020035137 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors
03/21/2002US20020035127 Phenylalanine derivatives
03/21/2002US20020035109 Benzamidine derivatives and their use as anti-coagulants
03/21/2002US20020035030 Contacting alpha-olefin with ransition metal complex of and Bronsted or Lewis acid to produce polyolefin
03/20/2002EP1188745A1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
03/20/2002EP1187827A1 Antiviral agents
03/20/2002EP1187810A2 Heterocyclic analgesic compounds and their use
03/20/2002EP1187592A2 Alpha v integrin receptor antagonists
03/19/2002US6358504 Compounds and compositions for delivering active agents
03/14/2002WO2002020465A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
03/14/2002WO2002020463A2 Fxr modulators
03/14/2002WO2001074790A3 Novel compounds for enhancing chemotherapy
03/14/2002WO2001068612A3 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
03/14/2002WO2001058852A3 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils
03/14/2002US20020032334 Oligomers and polymers of di-substituted cyclic imino carboxylic acids
03/14/2002US20020032223 Benzamidine derivatives and their use as anti-coagulants
03/14/2002US20020032202 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia
03/14/2002DE10041402A1 Neue Verbindungen, die Faktor Xa-Aktivität inhibieren Novel compounds which inhibit factor Xa activity